fluconazole has been researched along with Hakim Syndrome in 1 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tiraboschi, I | 1 |
| Casas Parera, I | 1 |
| Pikielny, R | 1 |
| Scattini, G | 1 |
| Micheli, F | 1 |
1 other study available for fluconazole and Hakim Syndrome
| Article | Year |
|---|---|
Chronic Histoplasma capsulatum infection of the central nervous system successfully treated with fluconazole.
Topics: Cerebrospinal Fluid Shunts; Diagnosis, Differential; Fluconazole; Histoplasmosis; Humans; Hydrocepha | 1992 |